Analytical Services Center for Medications Development Programview on SAM.gov

HEALTH AND HUMAN SERVICES, DEPARTMENT OF › NATIONAL INSTITUTES OF HEALTH NIDA

Posted Jul 17, 2026

Bethesda, MD

NAICS 541715 – Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Sol # 75N98026D00031

Awardee: MRIGLOBAL

AI Summary

• Contract No. 75N98026D00031 is awarded to MRIGlobal for the Analytical Services Center at NIDA.
• The task order will run for five (5) years with an initial performance period of one year plus four option periods over a minimum two-year commitment;
• Responses are due July 17, 2023

Description

NOTICE OF AWARD. THIS IS NOT A REQUEST FOR QUOTE/PROPOSALS. On July 17, 2022; in response to the requirements of Solicitation 75N95024R00032, the National Institute on Drug Abuse (NIDA) awarded Contract No. 75N98026D00031 to MRIGlobal for the Analytical Services Center for Medications Development . NIDA anticipates the use of Task Orders with an ultimate Period of Performance of five (5) years. An award shall be made on a Cost Plus Fixed Fee and Firm Fixed Price basis.

Award Details

Contract #75N98026D00031

Award DateJul 17, 2026

Amount$5.0M

AwardeeMRIGLOBAL

UEIHKQHNFKNKL15

CAGE21165

Awardee LocationKansas City, MO, 64110

Classification

NAICS541715

PSC CodeAN11

Place of Performance